Loading...
XKRX
086450
Market cap559mUSD
Dec 05, Last price  
18,750.00KRW
1D
-0.79%
1Q
10.42%
Jan 2017
-67.33%
IPO
-50.00%
Name

Dongkook Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XKRX:086450 chart
P/E
13.46
P/S
1.01
EPS
1,392.75
Div Yield, %
—
Shrs. gr., 5y
0.01%
Rev. gr., 5y
10.99%
Revenues
812.17b
+11.10%
180,296,024,780213,086,061,880226,014,177,940259,929,994,536309,690,117,405354,767,875,845400,807,087,433482,280,354,140559,103,459,208594,193,122,293661,647,492,300730,993,597,320812,166,073,000
Net income
61.22b
+29.77%
22,312,055,73016,763,567,22021,098,324,75027,425,742,72040,659,764,61439,601,738,02546,948,799,03356,312,245,52155,925,025,30050,345,220,67052,895,926,99047,175,202,52061,218,953,000
CFO
76.09b
+82.07%
14,203,464,12019,860,053,29022,737,479,93027,903,635,67740,283,996,74829,330,523,78734,698,059,58769,391,677,07459,676,440,41144,246,515,76949,158,510,02841,792,950,67076,090,783,000
Dividend
Dec 27, 2023180 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various natural product materials, such as black cohosh extract and magnolia extract comprises ETIZM and TECA; and natural herb medicines. In addition, it provides general and prescription-based drugs; medical devices; ETC and cosmetic products; and quasi drugs that include lipossol hydrocare bandage. DongKook Pharmaceutical Co., Ltd. also exports its products to approximately 40 countries, including Japan, Europe, Central and South America, and India. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.
URL
http://www.dkpharm.co.kr/
IPO date
May 29, 2007
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT